Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications

ISSN： 1360-8185

Source： Apoptosis, Vol.15, Iss.11, 2010-11, pp. : 1292-1311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Could carnosine suppress zinc-mediated proteasome inhibition and neurodegeneration? Therapeutic potential of a non-toxic but non-patentable dipeptide

By Hipkiss Alan

Biogerontology, Vol. 6, Iss. 2, 2005-03 ,pp. : 147-149

Springer Publishing Company

Access to resources Recommend Favorite

Adeno-Associated Virus Type 2 Vector-Mediated Glial Cell Line-Derived Neurotrophic Factor Gene Transfer Induces Neuroprotection and Neuroregeneration in a Ubiquitin-Proteasome System Impairment Animal Model of Parkinson’s Disease

Neurodegenerative Diseases, Vol. 11, Iss. 3, 2012-05 ,pp. : 113-128

Karger

Access to resources Recommend Favorite

2-Methoxyestardiol and bortezomib/proteasome-inhibitor overcome dexamethasone-resistance in multiple myeloma cells by modulating Heat Shock Protein-27

By Chauhan D.

Apoptosis, Vol. 9, Iss. 2, 2004-03 ,pp. : 149-155

Springer Publishing Company

Access to resources Recommend Favorite

Conservation of linkage and evolution of developmental function within the Tbx2/3/4/5 subfamily of T-box genes: implications for the origin of vertebrate limbs

By Horton Amy

Development Genes and Evolution, Vol. 218, Iss. 11-12, 2008-12 ,pp. : 613-628

Springer Publishing Company

Access to resources Recommend Favorite

Fas/FasL pathway-mediated alveolar macrophage apoptosis involved in human silicosis

By Yao San-qiao

Apoptosis, Vol. 16, Iss. 12, 2011-12 ,pp. : 1195-1204

Springer Publishing Company

Access to resources Recommend Favorite